Beraprost


Concise Prescribing Info
Indications/Uses
Listed in Dosage.
Dosage/Direction for Use
Adult : PO Peripheral vascular disease 120 mcg/day. Primary pulmonary HTN Initial: 60 mcg/day in 3 divided doses. Up to 180 mcg/day in 3-4 divided doses if needed.
Dosage Details
Oral
Peripheral vascular disease
Adult: 120 mcg/day in 3 divided doses.

Oral
Primary pulmonary hypertension
Adult: Initially, 60 mcg daily, given in 3 divided doses, may increase to 180 mcg daily, given in 3-4 divided doses if necessary.
Administration
Should be taken with food.
Contraindications
Patients with haemorrhage. Pregnancy.
Special Precautions
Patients on anticoagulants, antiplatelet or fibrinolytic agents. Menstruating women, patients with bleeding tendency or diathesis. May enhance bleeding tendency.
Adverse Reactions
Headache, hot flushes, GI upset, bleeding tendency, dizziness. Increased liver enzymes, triglycerides and bilirubin.
Drug Interactions
Anticoagulants, antiplatelet, fibrinolytic agents or any product that intensifies bleeding tendency. Prostaglandin I2 preparations.
Action
Description: Beraprost is a synthetic analog of epoprostenol (a prostaglandin) which causes vasodilatation and prevents platelet aggregation.
Disclaimer: This information is independently developed by MIMS based on Beraprost from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in